Similarly, CAF-derived miR-130a mediates the chemoresistance to cisplatin in non-small cell lung cancer (NSCLC) cells [23] and CAF-derived miR-106b promotes the resistance to gemcitabine by targeting TP53INP1 in pancreatic cancer [57]. The gene discussed is TP53INP1; the disease is non-small cell lung carcinoma.